Walgreens tops quarterly revenue estimates, but narrows profit outlook in ‘challenging’ economy
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., ...
Tag: Pharmaceuticals
Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ...
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket ...
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado ...
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
Nurphoto | Nurphoto | Getty ImagesPfizer is ready to move on from Covid. Now, the company is betting on cancer drugs ...
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Cr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target ...
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.Dado Ruvic ...
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. Victoria ...
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
